Bluejay Diagnostics (BJDX) Interest Coverage Ratio (2024 - 2025)
Bluejay Diagnostics' (BJDX) quarterly Interest Coverage Ratio came in at 7816.83 in Q4 2025, down 283.83% year-on-year from 4252.27 in Q4 2024, and up 3.31% quarter-over-quarter from 8084.74 in Q3 2025.
Bluejay Diagnostics (BJDX) Interest Coverage Ratio (2024 - 2025) Analysis & Trends
Bluejay Diagnostics has disclosed Interest Coverage Ratio across 2 years of filings, most recently posting 7816.83 for Q4 2025.
- Interest Coverage Ratio for Q4 2025 came in at 7816.83, down 283.83% year-over-year; the trailing twelve-month figure through Mar 2026 was 11498.99 (down 141730.8% YoY), and the FY2025 annual result was 8287.21, down 95032.13% from the prior year.
- Interest Coverage Ratio came in at 7816.83 for Q4 2025 at Bluejay Diagnostics, up from 8084.74 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 3.03 in Q2 2024 to a low of 8943.07 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 7.73 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 8.09 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 12.23 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -2.90 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 5.36 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 20.98 |
| 10 | Bluejay Diagnostics | 4.43 Mn | 746,549.00 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7,816.83 |
| Sep 30, 2025 | -8,084.74 |
| Jun 30, 2025 | -8,943.07 |
| Dec 31, 2024 | -2,036.55 |
| Sep 30, 2024 | -7.14 |
| Jun 30, 2024 | -3.03 |